Novartis AG Aims to Resurrect ‘Zombie’ Drug After Four Years

Bloomberg -- Novartis AG (NOVN) asked European Union regulators to approve the Prexige pain pill that was pulled off the market four years ago, as the company seeks to revive a drug that once had the potential for $1 billion in annual sales.